サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1386603

クローニングと突然変異誘発市場レポート：2030年までの動向、予測、競合分析

Cloning and Mutagenesis Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

クローニングと突然変異誘発市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月12日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

クローニングと突然変異誘発の動向と予測

世界のクローニングと突然変異誘発市場は、2024年から2030年までのCAGRが18.0%で、2030年までに推定70億米ドルに達すると予想されています。この市場の主な促進要因は、慢性疾患と遺伝性疾患の有病率の増加、クローニングと突然変異誘発技術の採用拡大、個別化医療に対する需要の高まりです。クローニングと突然変異誘発の世界市場の将来は、バイオ医薬品・製薬会社、CRO・CMO、学術・研究機関市場に機会があり、有望視されています。

クローニングと突然変異誘発市場の洞察

Lucintelは、クローニングキットは遺伝子治療、遺伝子解析、バイオ医薬品などの幅広い用途で採用が増加しているため、予測期間中も引き続き大きなセグメントであると予測しています。

この市場において、バイオ医薬品・製薬会社は、疾病の蔓延の増加により最大のセグメントであり続けると思われます。

北米は、バイオテクノロジー技術に対する需要の増加と主要企業の存在により、予測期間中最大の地域であり続けると思われます。

本レポートでは、以下の11の主要な質問に回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のクローニングと突然変異誘発市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のクローニングと突然変異誘発市場の動向（2018～2023年）および予測（2024～2030年）
  • 製品別の世界のクローニングと突然変異誘発市場
    • クローニングキット
    • 突然変異誘発キット
    • その他
  • 技術別の世界のクローニングと突然変異誘発市場
    • Topo PCRクローニング
    • ブラントエンドクローニング
    • シームレスクローン作成
    • その他
  • 最終用途別の世界のクローニングと突然変異誘発市場
    • バイオ医薬品および製薬会社
    • CROとCMO
    • 学術調査機関

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界のクローニングと突然変異誘発市場
  • 北米のクローニングと突然変異誘発市場
  • 欧州のクローニングと突然変異誘発市場
  • アジア太平洋のクローニングと突然変異誘発市場
  • その他地域クローニングと突然変異誘発市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品別の世界のクローニングと突然変異誘発市場の成長機会
    • 技術別の世界のクローニングと突然変異誘発市場の成長機会
    • 最終用途別の世界のクローニングと突然変異誘発市場の成長機会
    • 地域別の世界のクローニングと突然変異誘発市場の成長機会
  • 世界のクローニングと突然変異誘発市場における新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のクローニングと突然変異誘発市場の能力拡大
    • 世界のクローニングと突然変異誘発市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Takara Bio
  • Agilent Technologies
  • Thermo Fisher Scientific
  • New England Biolabs
  • Merck
  • Promega
  • Bio-Rad Laboratories
  • Danaher
  • Jena Bioscience
  • Assay Genie
目次

Cloning and Mutagenesis Trends and Forecast

The future of the global cloning and mutagenesis market looks promising with opportunities in the biopharmaceutical & pharmaceutical company, CROs & CMOs, and academic & research institute markets. The global cloning and mutagenesis market is expected to reach an estimated $7 billion by 2030 with a CAGR of 18.0% from 2024 to 2030. The major drivers for this market are increasing prevalence of chronic diseases and genetic disorders, growing adoption of cloning and mutagenesis technologies, and rising demand for personalized medicine.

A more than 150-page report is developed to help in your business decisions.

Cloning and Mutagenesis by Segment

The study includes a forecast for the global cloning and mutagenesis by product, technology, end use, and region.

Cloning and Mutagenesis Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Cloning Kits
  • Mutagenesis Kits
  • Others

Cloning and Mutagenesis Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Topo PCR Cloning
  • Blunt end Cloning
  • Seamless Cloning
  • Others

Cloning and Mutagenesis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Biopharmaceutical & Pharmaceutical Companies
  • CROs & CMOs
  • Academic & Research Institutes

Cloning and Mutagenesis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cloning and Mutagenesis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cloning and mutagenesis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cloning and mutagenesis companies profiled in this report include-

  • Takara Bio
  • Agilent Technologies
  • Thermo Fisher Scientific
  • New England Biolabs
  • Merck
  • Promega
  • Bio-Rad Laboratories
  • Danaher
  • Jena Bioscience
  • Assay Genie

Cloning and Mutagenesis Market Insights

Lucintel forecasts that cloning kits will remain the larger segment over the forecast period due to its increasing adoption in a wide range of applications, such as gene therapy, gene analysis, and biopharmaceuticals.

Within this market, biopharmaceutical & pharmaceutical companies will remain the largest segment due to increasing prevalence of diseases.

North America will remain the largest region over the forecast period due to increasing demand for biotechnology techniques and presence of key players in the region.

Features of the Global Cloning and Mutagenesis Market

Market Size Estimates: Cloning and mutagenesis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cloning and mutagenesis market size by product, technology, end use, and region in terms of value ($B).

Regional Analysis: Cloning and mutagenesis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, technologies, end uses, and regions for the cloning and mutagenesis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cloning and mutagenesis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the cloning and mutagenesis market size?

Answer: The global cloning and mutagenesis market is expected to reach an estimated $7 billion by 2030.

Q.2 What is the growth forecast for cloning and mutagenesis market?

Answer: The global cloning and mutagenesis market is expected to grow with a CAGR of 18.0% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the cloning and mutagenesis market?

Answer: The major drivers for this market are increasing prevalence of chronic diseases and genetic disorders, growing adoption of cloning and mutagenesis technologies, and rising demand for personalized medicine.

Q4. What are the major segments for cloning and mutagenesis market?

Answer: The future of the cloning and mutagenesis market looks promising with opportunities in the biopharmaceutical & pharmaceutical company, CROs & CMOs, and academic & research institute markets.

Q5. Who are the key cloning and mutagenesis market companies?

Answer: Some of the key cloning and mutagenesis companies are as follows:

  • Takara Bio
  • Agilent Technologies
  • Thermo Fisher Scientific
  • New England Biolabs
  • Merck
  • Promega
  • Bio-Rad Laboratories
  • Danaher
  • Jena Bioscience
  • Assay Genie

Q6. Which cloning and mutagenesis market segment will be the largest in future?

Answer: Lucintel forecasts that cloning kits will remain the larger segment over the forecast period due to its increasing adoption in a wide range of applications, such as gene therapy, gene analysis, and biopharmaceuticals.

Q7. In cloning and mutagenesis market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing demand for biotechnology techniques and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cloning and mutagenesis market by product (cloning kits, mutagenesis kits, and others), technology (topo PCR cloning, blunt end cloning, seamless cloning, and others), end use (biopharmaceutical & pharmaceutical companies, CROs & CMOs, and academic & research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cloning and Mutagenesis Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cloning and Mutagenesis Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cloning and Mutagenesis Market by Product
    • 3.3.1: Cloning Kits
    • 3.3.2: Mutagenesis Kits
    • 3.3.3: Others
  • 3.4: Global Cloning and Mutagenesis Market by Technology
    • 3.4.1: Topo PCR Cloning
    • 3.4.2: Blunt end Cloning
    • 3.4.3: Seamless Cloning
    • 3.4.4: Others
  • 3.5: Global Cloning and Mutagenesis Market by End Use
    • 3.5.1: Biopharmaceutical & Pharmaceutical Companies
    • 3.5.2: CROs & CMOs
    • 3.5.3: Academic & Research Institutes

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cloning and Mutagenesis Market by Region
  • 4.2: North American Cloning and Mutagenesis Market
    • 4.2.2: North American Cloning and Mutagenesis Market by End Use: Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes
  • 4.3: European Cloning and Mutagenesis Market
    • 4.3.1: European Cloning and Mutagenesis Market by Product: Cloning Kits, Mutagenesis Kits, and Others
    • 4.3.2: European Cloning and Mutagenesis Market by End Use: Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes
  • 4.4: APAC Cloning and Mutagenesis Market
    • 4.4.1: APAC Cloning and Mutagenesis Market by Product: Cloning Kits, Mutagenesis Kits, and Others
    • 4.4.2: APAC Cloning and Mutagenesis Market by End Use: Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes
  • 4.5: ROW Cloning and Mutagenesis Market
    • 4.5.1: ROW Cloning and Mutagenesis Market by Product: Cloning Kits, Mutagenesis Kits, and Others
    • 4.5.2: ROW Cloning and Mutagenesis Market by End Use: Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cloning and Mutagenesis Market by Product
    • 6.1.2: Growth Opportunities for the Global Cloning and Mutagenesis Market by Technology
    • 6.1.3: Growth Opportunities for the Global Cloning and Mutagenesis Market by End Use
    • 6.1.4: Growth Opportunities for the Global Cloning and Mutagenesis Market by Region
  • 6.2: Emerging Trends in the Global Cloning and Mutagenesis Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cloning and Mutagenesis Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cloning and Mutagenesis Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Takara Bio
  • 7.2: Agilent Technologies
  • 7.3: Thermo Fisher Scientific
  • 7.4: New England Biolabs
  • 7.5: Merck
  • 7.6: Promega
  • 7.7: Bio-Rad Laboratories
  • 7.8: Danaher
  • 7.9: Jena Bioscience
  • 7.10: Assay Genie